Continental natural gas futures closed up 6.7% Thursday at a record high, with European gas prices already ten times higher than usual for this time of year. Benchmark electricity prices in Europe also hit a new record Thursday, deepening an energy crisis that is piling pressure on businesses and households across the region. Dutch gas futures, the continental European TTF benchmark, closed 6.7% higher on Thursday, after breaking through the August 15 top to close at €241.000 / MWH, a new record set in early March this year.
European gas prices are already ten times higher than normal for this time of year. The surge is being followed by European electricity prices, which will also soar to record highs in Germany, France and Denmark next year.
Europe's energy crisis has intensified since the Russia-Ukraine conflict. The rare drought across Europe has added to the problems of inland waterway navigation as the Rhine falls, hydroelectric power as the rivers dry up, and a food crisis caused by dry land and frequent wildfires.
In the face of this crisis, neither the industrial sector nor the ordinary people, no one can escape.
As the Wall Street Journal noted in an earlier article, Europe's energy-hungry industries have been hit hard by natural and man-made disasters. The high cost of energy has forced many of the country's biggest industrial giants to "take the plunge".
Start with the commodities sector, the bedrock of the global economy. Energy-intensive industries such as steel, fertiliser and aluminium are being forced to close factories or pass on soaring costs, while materials crucial for electric car batteries and solar power are also under intense pressure. Europe has lost about half of its zinc and aluminium smelting capacity in the past year, with more likely to be shut down soon.
European fertiliser companies, which rely on natural gas to produce key nutrients, are now having to cut back again. At least a quarter of Europe's nitrogen fertilizer production capacity has been lost, according to media reports. The International Fertilizer Council predicts that global nitrogen use will fall the most in the coming quarter since 2008.
Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables or 0.2 pcr tubes . Welcome to contact GENETURE or Send an email to: email@example.com and our professional sales engineer will get back to you within 48 hours.
Analysis and forecast of the market size of PCR diagnostic industry
Polymerase chain reaction (PCR) is a nucleic acid synthesis technology that uses the principle of DNA double-strand replication to replicate specific DNA fragments in vitro. With this technology, the detection equipment can amplify the target gene in a large number in a short time, expanding the target gene fragment to the order of millions to billions, thus achieving high sensitivity detection. At present, polymerase chain reaction (PCR) diagnosis of infectious diseases such as hepatitis, venereal disease, intestinal respiratory disease and tumor single gene detection is an important application field. In 2020, polymerase chain reaction (PCR) diagnostic technology was identified as the "gold standard" for COVID-19 diagnosis due to its high sensitivity and accuracy.
China's PCR diagnostic market is developing rapidly, with the market size growing rapidly from about RMB 2.37 billion in 2015 to about RMB 5.93 billion in 2019, with a compound annual growth rate of 25.8%. China's PCR industry experienced explosive growth due to the huge demand for testing caused by the outbreak of COVID-19 in 2020, and the market size of China's PCR diagnostic industry exceeded 10 billion yuan in 2020. With the introduction of a large number of PCR diagnostic instruments, the PCR diagnostic industry will enter a new stage of development. It is expected that the PCR diagnostic industry will maintain a double-digit growth rate, and the market size of the PCR diagnostic industry will reach about 23.42 billion yuan in 2030 based on the factory price, and the cagR will reach about 13.3% from 2019 to 2030.
Market Demand of the 0.2 pcr tubes
The DNA/RNA Extraction Kit market and other 0.2 pcr tubes s are projected to grow at a CAGR of 8.26% during the forecast period 2022-2027.
The COVID-19 pandemic has impacted the 0.2 pcr tubes market for a short time due to restrictions on different business and research activities for 0.2 pcr tubes s. In addition, diagnostic tests for other diseases and medical conditions in hospitals and other clinical diagnostic facilities have been affected as COVID-19 has led to fewer patients taking tests. However, the high rate of COVID-19 infection and research activities are undertaken by major companies in the field of sequencing to expand their understanding of the virus and its origins, as well as molecular diagnostics of the SARS-COV-2 virus, have led to the development and launch of many DNA - and RNA-BASED COVID-19 kits, The kits proved so important that they were in great demand.
Market drivers for the 0.2 pcr tubes
The growth of the DNA/RNA extraction kit market is primarily driven by increased investment in R&D activities in different areas, including molecular diagnostics for different chronic and infectious diseases. For example, the US spent $842 billion on R&D activities in 2020, followed by China at $664 billion, according to the ORGANISATION for Economic Co-operation and Development. Technological advances worldwide, new product launches by major market players, and an increase in cancer cases are also likely to complement the growth of the markets under study.
Other factors, such as increased demand for automation of DNA/RNA extraction technologies, new user-friendly and easy extraction kits, and DNA/RNA for analysis of new diseases causing microorganisms, are expected to drive DNA/RNA growth. RNA Extraction Kit market during the forecast period. Therefore, low awareness and availability of the kit and low market penetration in less developed and developing regions around the world are the major factors limiting the growth of the DNA/RNA extraction kit market.
North America is expected to dominate the global 0.2 pcr tubes market during the forecast period
North America, which holds a major share in the 0.2 pcr tubes market, is expected to show a similar trend during the forecast period, mainly due to the high level of R&D activity in the region and the presence of major market players in the region constantly developing their products for the markets studied.
In the region, the US is expected to take a major share of the DNA/RNA extraction kit market due to heavy investment in R&D by government and private entities, increased demand for 0.2 pcr tubes s, and the rising prevalence of chronic diseases.
The 0.2 pcr tubes professional supplier manufacturer -Geneture
Geneture is a professional supplier of Nucleic Acid Extraction Reagent,Automatic Nucleic Acid Extraction,Lab consumables, Real-time PCR, Covid-19 Rapid Test Supplier. Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables.
Feel free to get a qutoe send an email to: firstname.lastname@example.org and our professional sales engineer will get back to you within 48 hours.
15+ years of experience
Over $50+ million in sales
14+ years of experience
Over $50+ million in sales
About Metal Alloy High Purity Tungsten Crucibles:Chemical composition:…
About Metal Alloy Vacuum Coating Tungsten Melting Pot Tungsten Crucibles:Chemical composition:…